SBP solbec pharmaceuticals limited

progen granted orphan drug status, page-7

  1. keith bogucki
    40 Posts.
    clock Created with Sketch.
    04/05/04
    17:44
    Post #: 456954
    Tom

    If you have a look at Solbec's Development Strategy, they are targeting both Mesothelioma & Melanoma (both relatively low-incidence cancers) in achieving Orphan Drug approval.

    It was very interesting to see Progen has achieved OD approval only 3 months after commencing Phase 11 trials......
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
RC1 Redcastle Delivers Positive Scoping Study for Queen Alexandra
right-arrow Created with Sketch.
NEWS Bellevue Gold: FY26 guidance and annual Resource & Reserve statement
right-arrow Created with Sketch.
AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises
right-arrow Created with Sketch.
NEWS The Watchlist - Hear from ASX Leaders!
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.